USPTO Patent Application for Clot Aspiration and Blood Reinfusion Systems
Summary
The USPTO has published a patent application (US20260083467A1) for clot aspiration and blood reinfusion systems. The application details devices, systems, and methods for aspirating clot material and blood from a patient's vasculature, filtering the blood, and returning it. The filing date was September 19, 2025.
What changed
The United States Patent and Trademark Office (USPTO) has published patent application US20260083467A1, titled 'CLOT ASPIRATION AND BLOOD REINFUSION SYSTEMS, AND ASSOCIATED DEVICES AND METHODS.' The application, filed on September 19, 2025, by inventors Jared Shimizu, Donald Joseph Fuller, Parker Ozenne, Anna Kristine Kratochvil, and Jakub Marek Truty, describes a system comprising an aspiration catheter, a reinfusion catheter, a collection chamber, a pump assembly, and a control system. This technology aims to aspirate clot material and blood from a patient's vasculature, filter the blood, and reinfuse it.
This publication represents a new patent application and does not impose immediate regulatory obligations on medical device manufacturers or healthcare providers. However, it signifies potential future innovation and market developments in cardiovascular intervention devices. Companies involved in developing or manufacturing medical devices for clot removal or blood management should monitor this and related patent filings for competitive intelligence and potential licensing opportunities. No compliance actions are immediately required based on this patent application publication.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CLOT ASPIRATION AND BLOOD REINFUSION SYSTEMS, AND ASSOCIATED DEVICES AND METHODS
Application US20260083467A1 Kind: A1 Mar 26, 2026
Inventors
Jared Shimizu, Donald Joseph Fuller, Parker Ozenne, Anna Kristine Kratochvil, Jakub Marek Truty
Abstract
Disclosed herein are devices, systems, and methods for aspirating clot material and blood from the vasculature of a patient, filtering the blood from the clot material, and returning the filtered blood to the vasculature of the patient. In some embodiments, a system in accordance with the present technology can include (i) an aspiration catheter configured to be positioned within the vasculature of a patient proximate to clot material therein, (ii) a reinfusion catheter configured to be positioned within the vasculature, (iii) a collection chamber selectively fluidly coupled to the aspiration catheter and the reinfusion catheter, (iv) a pump assembly selectively fluidly coupled to the collection chamber and configured to generate positive and negative pressure within the collection chamber, and (v) a control system configured to selectively control the fluid couplings to perform clot aspiration and filtered blood reinfusion operations.
CPC Classifications
A61B 17/22 A61M 1/74 A61M 39/24 A61B 2017/00561 A61B 2217/005 A61M 2039/0009 A61M 2039/248 A61M 2202/0021 A61M 2202/0413 A61M 2205/3331 A61M 2205/7545 A61M 2210/12
Filing Date
2025-09-19
Application No.
19334624
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.